These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 14678746)

  • 1. Zebrafish embryos express an orthologue of HERG and are sensitive toward a range of QT-prolonging drugs inducing severe arrhythmia.
    Langheinrich U; Vacun G; Wagner T
    Toxicol Appl Pharmacol; 2003 Dec; 193(3):370-82. PubMed ID: 14678746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of zebrafish embryos as a model for assessing inhibition of hERG.
    Mittelstadt SW; Hemenway CL; Craig MP; Hove JR
    J Pharmacol Toxicol Methods; 2008; 57(2):100-5. PubMed ID: 18291682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deficient zebrafish ether-à-go-go-related gene channel gating causes short-QT syndrome in zebrafish reggae mutants.
    Hassel D; Scholz EP; Trano N; Friedrich O; Just S; Meder B; Weiss DL; Zitron E; Marquart S; Vogel B; Karle CA; Seemann G; Fishman MC; Katus HA; Rottbauer W
    Circulation; 2008 Feb; 117(7):866-75. PubMed ID: 18250272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two isoforms of the mouse ether-a-go-go-related gene coassemble to form channels with properties similar to the rapidly activating component of the cardiac delayed rectifier K+ current.
    London B; Trudeau MC; Newton KP; Beyer AK; Copeland NG; Gilbert DJ; Jenkins NA; Satler CA; Robertson GA
    Circ Res; 1997 Nov; 81(5):870-8. PubMed ID: 9351462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. QT interval prolongation and cardiac risk assessment for novel drugs.
    Picard S; Lacroix P
    Curr Opin Investig Drugs; 2003 Mar; 4(3):303-8. PubMed ID: 12735231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toward a pharmacophore for drugs inducing the long QT syndrome: insights from a CoMFA study of HERG K(+) channel blockers.
    Cavalli A; Poluzzi E; De Ponti F; Recanatini M
    J Med Chem; 2002 Aug; 45(18):3844-53. PubMed ID: 12190308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A structural basis for drug-induced long QT syndrome.
    Mitcheson JS; Chen J; Lin M; Culberson C; Sanguinetti MC
    Proc Natl Acad Sci U S A; 2000 Oct; 97(22):12329-33. PubMed ID: 11005845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The anti-malarial drug halofantrine and its metabolite N-desbutylhalofantrine block HERG potassium channels.
    Mbai M; Rajamani S; January CT
    Cardiovasc Res; 2002 Sep; 55(4):799-805. PubMed ID: 12176129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The hERG channel activator, RPR260243, enhances protective
    Shi YP; Pang Z; Venkateshappa R; Gunawan M; Kemp J; Truong E; Chang C; Lin E; Shafaattalab S; Faizi S; Rayani K; Tibbits GF; Claydon VE; Claydon TW
    Am J Physiol Heart Circ Physiol; 2020 Aug; 319(2):H251-H261. PubMed ID: 32559136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular determinants of high-affinity drug binding to HERG channels.
    Mitcheson JS; Perry MD
    Curr Opin Drug Discov Devel; 2003 Sep; 6(5):667-74. PubMed ID: 14579516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pharmacokinetic-pharmacodynamic model for the quantitative prediction of dofetilide clinical QT prolongation from human ether-a-go-go-related gene current inhibition data.
    Jonker DM; Kenna LA; Leishman D; Wallis R; Milligan PA; Jonsson EN
    Clin Pharmacol Ther; 2005 Jun; 77(6):572-82. PubMed ID: 15961988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased risk of arrhythmic events in long-QT syndrome with mutations in the pore region of the human ether-a-go-go-related gene potassium channel.
    Moss AJ; Zareba W; Kaufman ES; Gartman E; Peterson DR; Benhorin J; Towbin JA; Keating MT; Priori SG; Schwartz PJ; Vincent GM; Robinson JL; Andrews ML; Feng C; Hall WJ; Medina A; Zhang L; Wang Z
    Circulation; 2002 Feb; 105(7):794-9. PubMed ID: 11854117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of the receptor binding and HERG channel affinities for a series of antipsychotic drugs.
    Kongsamut S; Kang J; Chen XL; Roehr J; Rampe D
    Eur J Pharmacol; 2002 Aug; 450(1):37-41. PubMed ID: 12176106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative pharmacology of guinea pig cardiac myocyte and cloned hERG (I(Kr)) channel.
    Davie C; Pierre-Valentin J; Pollard C; Standen N; Mitcheson J; Alexander P; Thong B
    J Cardiovasc Electrophysiol; 2004 Nov; 15(11):1302-9. PubMed ID: 15574182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of visualized transgenic zebrafish as a high throughput model to assay bradycardia related cardio toxicity risk candidates.
    Wen D; Liu A; Chen F; Yang J; Dai R
    J Appl Toxicol; 2012 Oct; 32(10):834-42. PubMed ID: 22744888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmia.
    Abbott GW; Sesti F; Splawski I; Buck ME; Lehmann MH; Timothy KW; Keating MT; Goldstein SA
    Cell; 1999 Apr; 97(2):175-87. PubMed ID: 10219239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reconstitution of defective protein trafficking rescues Long-QT syndrome in zebrafish.
    Meder B; Scholz EP; Hassel D; Wolff C; Just S; Berger IM; Patzel E; Karle C; Katus HA; Rottbauer W
    Biochem Biophys Res Commun; 2011 May; 408(2):218-24. PubMed ID: 21458413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of cardiac delayed rectifier K+ current by overexpression of the long-QT syndrome HERG G628S mutation in transgenic mice.
    Babij P; Askew GR; Nieuwenhuijsen B; Su CM; Bridal TR; Jow B; Argentieri TM; Kulik J; DeGennaro LJ; Spinelli W; Colatsky TJ
    Circ Res; 1998 Sep; 83(6):668-78. PubMed ID: 9742063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel.
    Sanguinetti MC; Jiang C; Curran ME; Keating MT
    Cell; 1995 Apr; 81(2):299-307. PubMed ID: 7736582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug binding to aromatic residues in the HERG channel pore cavity as possible explanation for acquired Long QT syndrome by antiparkinsonian drug budipine.
    Scholz EP; Zitron E; Kiesecker C; Lueck S; Kathöfer S; Thomas D; Weretka S; Peth S; Kreye VA; Schoels W; Katus HA; Kiehn J; Karle CA
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Nov; 368(5):404-14. PubMed ID: 14557918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.